Medical Oncology

Steven Patierno, PhD

Professor of Medicine
Professor of Pharmacology and Cancer Biology
Professor in Family Medicine and Community Health
Member of the Duke Cancer Institute
Campus mail 10 Bryan Searle Drive, Seeley Mudd Building, Suite 413, Durham, NC 27710
Phone (919) 613-5093
Email address steven.patierno@duke.edu

Patierno's current translational research interests are focused on the genomics molecular biology of cancer disparities, cancer biology, molecular pharmacology and targeted experimental therapeutics to control prostate, breast and lung tumor aggressiveness. He is an internationally recognized expert in cancer control, cancer causation and molecular carcinogenesis, which includes a broad spectrum of laboratory and population level research.   Patierno is also actively engaged in cancer health disparities and healthcare delivery research focused on patient navigation, survivorship, community-based interventions, mHealth, implementation sciences, cancer care economics, and policy.

Education and Training

  • Postdoctoral Training, Norris Comprehensive Cancer, University of Southern California, 1986 - 1988
  • Ph.D., University of Texas Medical School at Houston, 1985
  • B.S., University of Connecticut, 1981

Grants

Publications

Corbett, Cheyenne M., Tamara J. Somers, Christine M. Nuñez, Catherine M. Majestic, Rebecca A. Shelby, Valarie C. Worthy, Nadine J. Barrett, and Steven R. Patierno. “Evolution of a longitudinal, multidisciplinary, and scalable patient navigation matrix model.” Cancer Med, March 4, 2020. https://doi.org/10.1002/cam4.2950.

PMID
32129946
Full Text

Barrett, Nadine J., Elisa M. Rodriguez, Ronaldo Iachan, Terry Hyslop, Kearston L. Ingraham, Gem M. Le, Kelly Martin, et al. “Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers.” Cancer 126, no. 5 (March 1, 2020): 1077–89. https://doi.org/10.1002/cncr.32487.

PMID
31909824
Full Text

Patierno, S. R. “Prostate cancer in African American men.” Clinical Advances in Hematology and Oncology 18, no. 3 (March 1, 2020): 154–56.

Scholars@Duke

Valverde, Patricia A., Linda Burhansstipanov, Steven Patierno, Sharon Gentry, Andrea Dwyer, Karla L. Wysocki, Angela K. Patterson, Linda U. Krebs, Jean Sellers, and Danelle Johnston. “Findings from the National Navigation Roundtable: A call for competency-based patient navigation training.” Cancer 125, no. 24 (December 15, 2019): 4350–59. https://doi.org/10.1002/cncr.32470.

PMID
31503340
Full Text

Robinson, Timothy J., Jennifer A. Freedman, Muthana Al Abo, April E. Deveaux, Bonnie LaCroix, Brendon M. Patierno, Daniel J. George, and Steven R. Patierno. “Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities.” Clin Cancer Res 25, no. 10 (May 15, 2019): 2963–68. https://doi.org/10.1158/1078-0432.CCR-18-2445.

PMID
30755441
Full Text

Devi, Gayathri R., Holly Hough, Nadine Barrett, Massimo Cristofanilli, Beth Overmoyer, Neil Spector, Naoto T. Ueno, et al. “Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium.” J Cancer 10, no. 15 (2019): 3344–51. https://doi.org/10.7150/jca.31176.

PMID
31293637
Full Text

Ware, Kathryn E., Santosh Gupta, Jared Eng, Wen-Chi Foo, Lorin Crawford, Garland Austin, Bhairavy Puviindran, et al. “Abstract B038: Convergent hormone therapy resistance mediated by stress/dormancy-like pathways in prostate cancer.” In Poster Presentations  Proffered Abstracts. American Association for Cancer Research, 2018. https://doi.org/10.1158/1538-7445.prca2017-b038.

Full Text

Al Abo, Muthana, Steven R. Patierno, and Jennifer A. Freedman. “Alternative RNA splicing and prostate cancer aggressiveness.” In Cancer Research, 78:111–12. AMER ASSOC CANCER RESEARCH, 2018.

Scholars@Duke

Freedman, Jennifer A., Yanru Wang, Xuechan Li, Hongliang Liu, Patricia G. Moorman, Daniel J. George, Norman H. Lee, Terry Hyslop, Qingyi Wei, and Steven R. Patierno. “Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.” Carcinogenesis 39, no. 7 (July 3, 2018): 879–88. https://doi.org/10.1093/carcin/bgy062.

PMID
29726910
Full Text

LaCroix, Bonnie L., Brendon M. Patierno, Bruce A. Sullenger, Daniel J. George, Steven R. Patierno, and Jennifer A. Freedman. “Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer.” In Cancer Epidemiology Biomarkers & Prevention, 27:46–46. AMER ASSOC CANCER RESEARCH, 2018.

Scholars@Duke

Pages